Building on our solid operations in Europe, we are committed to creating a strong and sustainable clinical research infrastructure and bringing world-class health research skills and clinical trial execution to Africa
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
See below to learn more about our new identity.
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Recent Blog Posts
A spotlight on the Pharmalys Regulatory Affairs Unit
As clinical research expands rapidly across the African continent, the demand for strategic and locally grounded regulatory support is becoming more critical than ever. From clinical trial start-up to post-marketing activities, effective regulatory oversight is key to...
Pharmalys at the EDCTP Forum, Kigali 2025
Pharmalys participated as an exhibitor at the EDCTP Forum 2025, held from 15 to 20 June 2025 in Kigali, Rwanda. The event brought together a diverse community of stakeholders, providing a unique platform for collaboration, learning, and visibility. This year’s theme,...
July 2025 Newsletter: Female Genital Mutilation, Project Management Training, Pharmalys Regulatory Affairs and Study Start-Up Services
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical...